Related Experiment Video
Updated: Aug 16, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Single high-dose intravenous immunoglobulin therapy for kawasaki disease increases plasma viscosity
Reizo Baba1, Atsuko Shibata, Masahito Tsurusawa
1Department of Paediatrics, Aichi Medical University School of Medicine, Aichi, Japan. babar@aichi-med-u.ac.jp
Background:
Intravenous immunoglobulin therapy, widely used for various autoimmune and systemic inflammatory diseases including Kawasaki disease (KD), is occasionally associated with thromboembolic adverse effects caused by an abrupt increase in blood viscosity. Scarce information is available, however, regarding the effect of single high-dose immunoglobulin therapy for KD on blood viscosity.
Methods And Results:
Eleven boys and 5 girls (mean age: 2.1 years) with acute-phase KD underwent single high-dose immunoglobulin therapy. Plasma viscosity before the treatment was 1.18 centipoises (SD = 0.06), but it significantly rose to 1.34 centipoises (SD = 0.06) (p < 0.001). Multiple regression analysis revealed that, among various factors including hematocrit, plasma concentrations of total protein, immunoglobulin G (IgG), immunoglobulin A (IgA), and immunoglobulin M (IgM), only plasma IgG concentration was included in the model to explain plasma viscosity (R2 = 0.59, p < 0.001).
Conclusions:
Single high-dose regimen for acute-phase KD increases blood viscosity and therefore might increase the risk of thromboembolism.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Nonlinear Pharmacokinetics: Drug Elimination for IV Bolus Injection
Following the administration of a single intravenous (IV) bolus injection, we can determine the concentration of the drug in the plasma at any given time. This calculation is achieved using a specific equation that integrates the values of Vmax and KM.
We can also...
Rheumatic Heart Disease III: Medical Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention